US8673949-B2  Goodin et al., "Epothilones: Mechanism of Action and Biologic Activity," Journal of Clinical Oncology, 2004, vol. 22, No. 10; pp. 2015-2025.;  Document Disclosing Data (1).;  Document Disclosing Data (2).;  Andrieux, et al., "Microtubule Stabilizer Ameliorates Synaptic Function and Behavior in a Mouse Model for Schizophrenia", Biol. Psychiatry, vol. 60, pp. 1224-1230, 2006.;  Ballatore, et al. "Paclitaxel C-10 Carbamates: Potential Candidates for the Treatment of Neurodegenerative Tauopathies", Biorganic & Medicinal Chemistry Letters, vol. 17, pp. 3642-3646, 2007.;  Ballog et al., "Epothilones, a New Class of Microtubule-Stabilizing Agents with a Taxol-Like Mechanism of Action", Cancer Research, vol. 55, pp. 2325-2333, 1995.;  Brunden, K.R. et al., "Epothilone D Improves Microtubule Density, Axonal Integrity, and Cognition in a Transgenic Mouse Model of Tauopathy", The Journal of Neuroscience, vol. 30, No. 41, pp. 13861-13866 (Oct. 13, 2010).;  Chen, Yingzue, "Microtubule-Stabilizing Agents as a Potential Therapeutic Treatment for Alzheimer's Disease", Dissertation, Mar. 29, 2001.;  Chou et al., "Desoxyepothilone B: An Efficacious Microtubule-Targeted Antitumor Agent with a Promising in Vivo Profile Relative to Epothilone B", Proc. Natl. Acad. Sci. USA, pp. 9642-9647, 1998.;  Fellner et al., "Transport of Paclitaxel (Taxol) Across the Blood-Brain Barrier in Vitro and in Vivo", The Journal of Clinical Investigation, vol. 110, No. 9, pp. 1309-1318, 2002.;  Goodin et al., "Epothilones: Mechanism of Action and Biologic Activity", Journal of Clinical Oncology, vol. 22, No. 10, pp. 2015-2025 (2004).;  Hoffmann et al., "Sagopilone Crosses the Blood-Brain Barrier in Vivo to Inhibit Brain Tumor Growth and Metastases", Neuro-Oncology, pp. 159-166, 2009.;  Kolman, "Epothilone D (Kosan/Roche)", Current Opinion in Investigational Drugs, vol. 5, No. 6, pp. 657-667, 2004.;  Lace et al., "A Brief History of Tau: The Evolving View of the Microtubule-Associated Protein Tau in Neurodegenerative Diseases", Clinical Neuropathology, vol. 26, No. 2, pp. 43-58, 2007.;  Lee et al., "Microtubule Stabilizing Drugs for the Treatment of Alzheimer's Disease", Neurobiology of Aging, vol. 15, Supplement 2, pp. S87-S89, 1994.;  Zhang et al., "Microtubule-Binding Drugs Offset Tau Sequestration by Stabilizing Microtubules and Reversing Fast Axonal Transport Deficits in a Tauopathy Model", Proc. Natl. Acad. Sci. USA, vol. 102, No. 1, pp. 227-231, 2005.;  Zhong, Ziyang, Declaration Under 37 CFR 1.132 dated Apr. 25, 2007, U.S. Appl. No. 10/703,404.;  Andrieux, A. et al., The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders, Genes & Development, vol. 16, pp. 2350-2364 (2002).;  Nicolaou, K.C. et al., "Chemical Biology of Epothilones", Angew. Chem. Int. Ed., vol. 37, pp. 2014-2045 (1998).;  European Opposition Division's Decision Revoking EP 1711230 B1 (Jan. 18, 2011).;  Minutes from Oral Proceedings Before the Opposition Division (Feb. 14, 2011).;  Fifre, Alexandre, et al, "Microtubule-Associated Protein MAP1A, MAP1B, and MAP2 Proteolysis During Soluble Amyloid Beta-Peptide-Induced Neuronal Apoptosis," Journal of Biological Chemistry, 281(1), pp. 229-240, 2006.;  Michaelis, M.L., et al, "Protection Against Beta-Amyloid Toxicity in Primary Neurons by Paclitaxel (Taxol)," Journal of Neurochemistry, 70(4), pp. 1623-1627, 1998.WO2009132253-A1  ZHANG B ET AL: "Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model" PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA USA, vol. 102, no. 1, 4 January 2005 (2005-01-04), pages 227-231, XP002539191 ISSN: 0027-8424